InvVax was incorporated in January 2013. Located in sunny Southern California, it maintains a strong affiliation with the UCLA, where its technology was originally developed. InvVax has access to a wide network of leading investigators in diverse disciplines, including molecular virology, immunology, pharmacology, and clinical infectious diseases. As a fledgling company, we are seeking highly talented applicants for scientific, industrial, and management roles who are interested in building a novel platform for vaccine development, and have a burning desire to make a far-ranging impact on the global human population.